MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise to help researchers analyze and understand thousands of cancer-related proteins. These proteins may be useful as therapeutic targets, early detection signals or biomarkers of cancer treatment response for a number of disease types, including lung, colon, breast, ovarian, pancreatic, prostate...
Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in adults...